MANTUANO, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 179
NA - Nord America 68
EU - Europa 55
AF - Africa 8
SA - Sud America 5
Totale 315
Nazione #
US - Stati Uniti d'America 64
VN - Vietnam 58
CN - Cina 45
SG - Singapore 31
IT - Italia 24
HK - Hong Kong 11
KR - Corea 10
IN - India 6
DE - Germania 5
FR - Francia 5
GB - Regno Unito 5
BD - Bangladesh 4
BR - Brasile 4
NL - Olanda 4
JP - Giappone 3
PH - Filippine 3
PL - Polonia 3
TH - Thailandia 3
CA - Canada 2
CI - Costa d'Avorio 2
EG - Egitto 2
PT - Portogallo 2
SC - Seychelles 2
TW - Taiwan 2
UA - Ucraina 2
ZA - Sudafrica 2
AT - Austria 1
ES - Italia 1
FI - Finlandia 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
PR - Porto Rico 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 315
Città #
Singapore 22
Hefei 20
Hanoi 18
New York 18
San Jose 11
Ho Chi Minh City 10
Hong Kong 10
Seoul 9
Bologna 7
Ashburn 6
Council Bluffs 5
Munich 3
Abidjan 2
Bengaluru 2
Buffalo 2
Cairo 2
Da Nang 2
Falkenstein 2
Haiphong 2
Kaohsiung 2
Legnano 2
Milan 2
Nha Trang 2
Rome 2
Santa Clara 2
Shanghai 2
Slough 2
Tokyo 2
Wroclaw 2
Ahmedabad 1
Bangkok 1
Barcelona 1
Bari 1
Barnet 1
Batangas 1
Beijing 1
Boardman 1
Botticino 1
Bến Tre 1
Cabanatuan City 1
Caguas 1
Can Tho 1
Cape Town 1
Capão Bonito 1
Catania 1
Catanzaro 1
Caçapava 1
Charlotte 1
Chengdu 1
Chennai 1
City of London 1
Dallas 1
Dammam 1
Helsinki 1
Hải Dương 1
Jacksonville 1
Jiujiang 1
Johannesburg 1
Kamloops 1
Kingston 1
Kryvyi Rih 1
Kwai Chung 1
Kyiv 1
Lauterbourg 1
Lecherías 1
Leicester 1
Lopburi 1
Los Angeles 1
Milwaukee 1
Montreal 1
Ninh Bình 1
Paris 1
Philadelphia 1
Phủ Lý 1
Plano 1
Rohtak 1
Roubaix 1
Santa Maria 1
Seocho-gu 1
Shijiazhuang 1
Si Racha 1
Tampines New Town 1
Tarlac City 1
Thane 1
Tongling 1
Treviso 1
Uberaba 1
Vienna 1
Warsaw 1
Washington 1
Xinxiang 1
Zhengzhou 1
Totale 236
Nome #
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma 164
Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data 60
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50% 39
First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC 37
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis 29
Totale 329
Categoria #
all - tutte 603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20247 0 0 0 0 0 0 0 0 2 0 5 0
2024/202553 6 7 3 1 7 1 2 3 0 4 11 8
2025/2026269 15 19 15 10 4 1 7 8 105 52 33 0
Totale 329